Malvina Cremante

7PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 25, 2025
A Comprehensive Approach to Neoadjuvant Treatment of Locally Advanced Rectal Cancer.

Annalice Gandini, Stefania Sciallero, Valentino Martelli

|Aug 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.

Alessandra Damassi, Malvina Cremante, Alessio Signori

|May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.

Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini

|Apr 13, 2023
Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives.

Fabio Catalano, Malvina Cremante, Bruna Dalmasso

|Jan 04, 2023
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report.

Veronica Murianni, Luigi Cerbone, Pasquale Rescigno

|Mar 25, 2022
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management.

Roberto Borea, Diletta Favero, Alberto Miceli

Pageof 2

Frequent Collaborators

6 joint publications

Giuseppe Fornarini

5 joint publications

Sara Elena Rebuzzi

5 joint publications

Fabio Catalano

4 joint publications

Veronica Murianni